Literature DB >> 19067639

Tandem mass spectrometry as a novel tool for elucidating pituitary-thyroid relationships.

Jacqueline Jonklaas1, Steven J Soldin.   

Abstract

BACKGROUND: Our objective was to determine the performance of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in documenting both group and individual relationships between thyroid hormone and thyroid-stimulating hormone (TSH) concentrations.
METHODS: This was a prospective analysis of 50 euthyroid patients undergoing thyroidectomy. Thyroxine (T(4)), triiodothyronine (T(3)), free T(4) (FT(4)), and TSH levels were documented on two occasions before thyroidectomy. After thyroidectomy, patients were treated with levothyroxine (LT(4)) to achieve either a normal or low serum TSH concentration. All laboratory evaluations were repeated twice while patients were taking LT(4). Thyroid hormone concentrations were documented by both immunoassay and LC-MS/MS, and their relationship with TSH was studied both in the entire group and in individual patients pre- and postthyroidectomy.
RESULTS: FT(4) and total T(3) correlated better with the log-transformed TSH when measured by LC-MS/MS. Postthyroidectomy the closest correlation was between log TSH and FT(4) (r = 0.86, p < 0.001). The next best correlation was between log TSH and total T(3) (r = 0.71, p < 0.001). When all data points were combined, the slope of the relationship between log TSH and total T(3) was relatively blunted compared with the log TSH-FT(4) slope (slope - 0.39 vs. - 1.38; p < 0.001), perhaps suggesting autoregulation of T(3) in response to the altered conditions postthyroidectomy.
CONCLUSION: LC-MS/MS is an excellent tool for documenting the known physiological phenomenon of a log-linear relationship between TSH and thyroid hormone concentrations. In a group of patients studied pre- and postthyroidectomy, both FT(4) and total T(3) measured by tandem mass spectrometry correlate well with TSH. However, T(3) correlates slightly less well and has a relatively blunted relationship with the log-transformed TSH. These paired data suggest that in LT(4)-replaced patients T(3) concentrations are held stable in the face of fluctuating T(4) concentrations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19067639      PMCID: PMC2857453          DOI: 10.1089/thy.2008.0155

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  38 in total

1.  Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins.

Authors:  R Wang; J C Nelson; R M Weiss; R B Wilcox
Journal:  Thyroid       Date:  2000-01       Impact factor: 6.568

2.  Comparative multicentre study of a panel of thyroid tests using different automated immunoassay platforms and specimens at high risk of antibody interference.

Authors:  J Martel; N Després; C E Ahnadi; J F Lachance; J E Monticello; G Fink; A Ardemagni; G Banfi; J Tovey; P Dykes; R John; J Jeffery; A M Grant
Journal:  Clin Chem Lab Med       Date:  2000-08       Impact factor: 3.694

3.  Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt
Journal:  Thyroid       Date:  2003-01       Impact factor: 6.568

4.  Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry.

Authors:  Christina Wang; Don H Catlin; Laurence M Demers; Borislav Starcevic; Ronald S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

5.  Free thyroxine measured by equilibrium dialysis and nine immunoassays in sera with various serum thyroxine-binding capacities.

Authors:  Rémy Sapin; Michèle d'Herbomez
Journal:  Clin Chem       Date:  2003-09       Impact factor: 8.327

6.  Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome.

Authors:  Csaba Fekete; Balázs Gereben; Márton Doleschall; John W Harney; Jose Miguel Dora; Antonio C Bianco; Sumit Sarkar; Zsolt Liposits; William Rand; Charles Emerson; Imre Kacskovics; P Reed Larsen; Ronald M Lechan
Journal:  Endocrinology       Date:  2003-12-18       Impact factor: 4.736

7.  Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.

Authors:  Jacqueline Jonklaas; Bruce Davidson; Supna Bhagat; Steven J Soldin
Journal:  JAMA       Date:  2008-02-20       Impact factor: 56.272

8.  Isotope dilution tandem mass spectrometric method for T4/T3.

Authors:  Nadia Soukhova; Offie P Soldin; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2004-05       Impact factor: 3.786

9.  Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.

Authors:  Jacqueline Jonklaas; Hala Nsouli-Maktabi; Steven J Soldin
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

10.  Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations.

Authors:  Michèle d'Herbomez; Gérard Forzy; Françoise Gasser; Catherine Massart; Andrée Beaudonnet; Rèmy Sapin
Journal:  Clin Chem Lab Med       Date:  2003-07       Impact factor: 3.694

View more
  12 in total

1.  Is measurement of TT3 by immunoassay reliable at low concentrations? A comparison of the Roche Cobas 6000 vs. LC-MSMS.

Authors:  Likhona Siphe Masika; Zhen Zhao; Steven John Soldin
Journal:  Clin Biochem       Date:  2016-02-12       Impact factor: 3.281

Review 2.  DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?

Authors:  Kerry J Welsh; Steven J Soldin
Journal:  Eur J Endocrinol       Date:  2016-12       Impact factor: 6.664

Review 3.  Thyroid hormone testing by tandem mass spectrometry.

Authors:  Offie P Soldin; Steven J Soldin
Journal:  Clin Biochem       Date:  2010-08-04       Impact factor: 3.281

Review 4.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

5.  Comparison of FT4 with log TSH on the Abbott Architect ci8200: Pediatric reference intervals for free thyroxine and thyroid-stimulating hormone.

Authors:  Steven J Soldin; Luke L Cheng; Lisa Y Lam; Alice Werner; Alexander D Le; Offie P Soldin
Journal:  Clin Chim Acta       Date:  2009-11-24       Impact factor: 3.786

Review 6.  The interaction between thyroid and kidney disease: an overview of the evidence.

Authors:  Connie M Rhee
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-10       Impact factor: 3.243

7.  Correlation between Serum Levels of 3,3',5'-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and Immunoassay.

Authors:  Hiroyuki Sakai; Hidenori Nagao; Mamoru Sakurai; Takako Okumura; Yoshiyuki Nagai; Junpei Shikuma; Rokuro Ito; Tetsuya Imazu; Takashi Miwa; Masato Odawara
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

Review 8.  The Interplay Between Thyroid Dysfunction and Kidney Disease.

Authors:  Yoko Narasaki; Peter Sohn; Connie M Rhee
Journal:  Semin Nephrol       Date:  2021-03       Impact factor: 5.299

9.  TSH Measurement and Its Implications for Personalised Clinical Decision-Making.

Authors:  Rudolf Hoermann; John E M Midgley
Journal:  J Thyroid Res       Date:  2012-12-09

10.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.